Back to search

Article

Safety of Allogeneic Mesenchymal Stromal Cell Therapy Across Human Clinical Indications: A Systematic Review of Landmark Clinical Trials and Published Safety Evidence

2026-03-11

Abstract excerpt

<title>Abstract</title> <p>Background Allogeneic mesenchymal stromal cells (MSCs) have emerged as an off-the-shelf regenerative medicine platform across cardiovascular, pulmonary, musculoskeletal, autoimmune, gastrointestinal, and renal indications. Although individual clinical trials frequently describe favorable tolerability, safety reporting remains heterogeneous across studies, and the adverse event profile...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0d7db6d4-5e14-58ff-8992-02b64ab6fe65
DOI
10.21203/rs.3.rs-9064413/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Safety of Allogeneic Mesenchymal Stromal Cell Therapy Across Human Clinical Indications: A Systematic Review of Landmark Clinical Trials and Published Safety EvidenceDOI 10.21203/rs.3.rs-9064413/v1
ISSCR’s Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventionsSemantic proximity
Mesenchymal Stem/Stromal Cells: A Review for Its Use After Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity
Use of mesenchymal stem cells for therapy of cardiac disease.Semantic proximity
The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expectSemantic proximity
Effectiveness and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-AnalysisSemantic proximity
Safety Evaluation of Long-term Administration of Umbilical Mesenchymal Stem Cell-Derived Extracellular VesiclesSemantic proximity
Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?Semantic proximity
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trialSemantic proximity
Mesenchymal Stem Cells for Therapeutic PurposesSemantic proximity
The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 PatientsSemantic proximity
Biosafety and Bioefficacy Assessment of Human Mesenchymal Stem Cells: What do we Know so Far?Semantic proximity
Multicentre comparison of biological and functional properties of mesenchymal stromal cells from different sources cultivated using a harmonised manufacturing workflowSemantic proximity
Select a neighboring publication to make it the new centre.